Molecular aspects of anti-cancer drug action:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Weinheim [u.a.]
Verl. Chemie
1983
|
| Schriftenreihe: | Topics in molecular and structural biology
3 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | X, 404 S. Ill. |
| ISBN: | 3527261338 0895730790 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV000396303 | ||
| 003 | DE-604 | ||
| 005 | 19990811 | ||
| 007 | t| | ||
| 008 | 870612s1983 xx a||| |||| 00||| eng d | ||
| 020 | |a 3527261338 |9 3-527-26133-8 | ||
| 020 | |a 0895730790 |9 0-89573-079-0 | ||
| 035 | |a (OCoLC)11460023 | ||
| 035 | |a (DE-599)BVBBV000396303 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-703 |a DE-355 |a DE-20 |a DE-29 |a DE-210 |a DE-188 | ||
| 050 | 0 | |a RC271.C5 | |
| 082 | 0 | |a 616.99/4061 |2 19 | |
| 084 | |a VS 9100 |0 (DE-625)147725:253 |2 rvk | ||
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 245 | 1 | 0 | |a Molecular aspects of anti-cancer drug action |c ed. by Stephen Neidle ... |
| 264 | 1 | |a Weinheim [u.a.] |b Verl. Chemie |c 1983 | |
| 300 | |a X, 404 S. |b Ill. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Topics in molecular and structural biology |v 3 | |
| 650 | 7 | |a Acridines |2 gtt | |
| 650 | 7 | |a Anthracyclinen |2 gtt | |
| 650 | 7 | |a Anticarcinogene stoffen |2 gtt | |
| 650 | 7 | |a Bleomycine |2 gtt | |
| 650 | 7 | |a Nucleïnezuren |2 gtt | |
| 650 | 7 | |a Structuur-activiteit-relatie |2 gtt | |
| 650 | 4 | |a Antineoplastic Agents |x pharmacology | |
| 650 | 4 | |a Antineoplastic agents | |
| 650 | 4 | |a DNA | |
| 650 | 4 | |a Molecular biology | |
| 650 | 4 | |a Pharmacology, Experimental | |
| 650 | 0 | 7 | |a Cytostatikum |0 (DE-588)4068347-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a QSAR |0 (DE-588)4205429-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Wirkungsmechanismus |0 (DE-588)4292866-7 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 0 | 1 | |a QSAR |0 (DE-588)4205429-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Cytostatikum |0 (DE-588)4068347-3 |D s |
| 689 | 1 | 1 | |a Wirkungsmechanismus |0 (DE-588)4292866-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Neidle, Stephen |e Sonstige |4 oth | |
| 830 | 0 | |a Topics in molecular and structural biology |v 3 |w (DE-604)BV000015093 |9 3 | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000246134&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 943 | 1 | |a oai:aleph.bib-bvb.de:BVB01-000246134 | |
Datensatz im Suchindex
| _version_ | 1823607485059039232 |
|---|---|
| adam_text |
- 064 MOLECULAR ASPECTS OF ANTI-CANCER DRUG ACTION EDITED BY STEPHEN
NEIDLE CANCER RESEARCH CAMPAIGN BIOMOLECULAR STRUCTURE RESEARCH GROUP
KING'S COLLEGE UNIVERSITY OF LONDON AND MICHAEL J. WARING DEPARTMENT OF
PHARMACOLOGY UNIVERSITY OF CAMBRIDGE MEDICAL SCHOOL UNIVERSITATS-
BIBLIOTHEK M CONTENTS THE CONTRIBUTORS VII PREFACE IX 1 ANTITUMOUR
ACRIDINES WILLIAM A. DENNY, BRUCE C. BAGULEY, BRUCE F. CAIN AND MICHAEL
J. WARING 1 2 THE INTERACTIONS OF DAUNOMYCIN AND ADRIAMYCIN WITH NUCLEIC
ACIDS S. NEIDLE AND M. R. SANDERSON 35 3 NEW NATURAL, SEMISYNTHETIC AND
SYNTHETIC ANTHRACYCLINE DRUGS J. R. BROWN 57 4 MECHANISMS OF SELECTIVE
CYTOTOXICITY OF ADRIAMYCIN, DAUNOMYCIN AND RELATED ANTHRACYCLINES
HERBERT S. SCHWARTZ 93 5 MOLECULAR ASPECTS OF THE INTERACTION BETWEEN
QUINOXALINE ANTI- BIOTICS AND NUCLEIC ACIDS MICHAEL J. WARING AND KEITH
R. FOX 127 6 BLEOMYCIN LAWRENCE F. POVIRK 157 7 ACTION OF PLATINUM
ANTITUMOUR DRUGS J. J. ROBERTS AND M. P. PERA, JR. 183 8 MOLECULAR
STRUCTURE AND ANTITUMOUR ACIVITY OF ALKYLATING AGENTS DERRY E. V. WILMAN
AND THOMAS A. CONNORS ' 233 9 THE CHEMISTRY OF DNA DAMAGE BY ANTITUMOUR
DRUGS J. WILLIAM LOWN 283 10 BIOLOGICAL ASPECTS OF DNA DAMAGE BY
CROSSLINKING AGENTS KURTW.KOHN 315 11 INHIBITORS OF DIHYDROFOLATE
REDUCTASE B. ROTH, E. BLISS AND C.R. BEDDELL 363 INDEX 395 |
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV000396303 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.C5 |
| callnumber-search | RC271.C5 |
| callnumber-sort | RC 3271 C5 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | VS 9100 XH 3200 |
| ctrlnum | (OCoLC)11460023 (DE-599)BVBBV000396303 |
| dewey-full | 616.99/4061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4061 |
| dewey-search | 616.99/4061 |
| dewey-sort | 3616.99 44061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 cb4500</leader><controlfield tag="001">BV000396303</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19990811</controlfield><controlfield tag="007">t|</controlfield><controlfield tag="008">870612s1983 xx a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527261338</subfield><subfield code="9">3-527-26133-8</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0895730790</subfield><subfield code="9">0-89573-079-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)11460023</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV000396303</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-703</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-210</subfield><subfield code="a">DE-188</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">19</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9100</subfield><subfield code="0">(DE-625)147725:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular aspects of anti-cancer drug action</subfield><subfield code="c">ed. by Stephen Neidle ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim [u.a.]</subfield><subfield code="b">Verl. Chemie</subfield><subfield code="c">1983</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 404 S.</subfield><subfield code="b">Ill.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Topics in molecular and structural biology</subfield><subfield code="v">3</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Acridines</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anthracyclinen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anticarcinogene stoffen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bleomycine</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nucleïnezuren</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Structuur-activiteit-relatie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Molecular biology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology, Experimental</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">QSAR</subfield><subfield code="0">(DE-588)4205429-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Wirkungsmechanismus</subfield><subfield code="0">(DE-588)4292866-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">QSAR</subfield><subfield code="0">(DE-588)4205429-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Wirkungsmechanismus</subfield><subfield code="0">(DE-588)4292866-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Neidle, Stephen</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Topics in molecular and structural biology</subfield><subfield code="v">3</subfield><subfield code="w">(DE-604)BV000015093</subfield><subfield code="9">3</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000246134&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="943" ind1="1" ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-000246134</subfield></datafield></record></collection> |
| id | DE-604.BV000396303 |
| illustrated | Illustrated |
| indexdate | 2025-02-09T19:00:21Z |
| institution | BVB |
| isbn | 3527261338 0895730790 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-000246134 |
| oclc_num | 11460023 |
| open_access_boolean | |
| owner | DE-12 DE-703 DE-355 DE-BY-UBR DE-20 DE-29 DE-210 DE-188 |
| owner_facet | DE-12 DE-703 DE-355 DE-BY-UBR DE-20 DE-29 DE-210 DE-188 |
| physical | X, 404 S. Ill. |
| publishDate | 1983 |
| publishDateSearch | 1983 |
| publishDateSort | 1983 |
| publisher | Verl. Chemie |
| record_format | marc |
| series | Topics in molecular and structural biology |
| series2 | Topics in molecular and structural biology |
| spelling | Molecular aspects of anti-cancer drug action ed. by Stephen Neidle ... Weinheim [u.a.] Verl. Chemie 1983 X, 404 S. Ill. txt rdacontent n rdamedia nc rdacarrier Topics in molecular and structural biology 3 Acridines gtt Anthracyclinen gtt Anticarcinogene stoffen gtt Bleomycine gtt Nucleïnezuren gtt Structuur-activiteit-relatie gtt Antineoplastic Agents pharmacology Antineoplastic agents DNA Molecular biology Pharmacology, Experimental Cytostatikum (DE-588)4068347-3 gnd rswk-swf QSAR (DE-588)4205429-1 gnd rswk-swf Wirkungsmechanismus (DE-588)4292866-7 gnd rswk-swf Cytostatikum (DE-588)4068347-3 s QSAR (DE-588)4205429-1 s DE-604 Wirkungsmechanismus (DE-588)4292866-7 s Neidle, Stephen Sonstige oth Topics in molecular and structural biology 3 (DE-604)BV000015093 3 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000246134&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Molecular aspects of anti-cancer drug action Topics in molecular and structural biology Acridines gtt Anthracyclinen gtt Anticarcinogene stoffen gtt Bleomycine gtt Nucleïnezuren gtt Structuur-activiteit-relatie gtt Antineoplastic Agents pharmacology Antineoplastic agents DNA Molecular biology Pharmacology, Experimental Cytostatikum (DE-588)4068347-3 gnd QSAR (DE-588)4205429-1 gnd Wirkungsmechanismus (DE-588)4292866-7 gnd |
| subject_GND | (DE-588)4068347-3 (DE-588)4205429-1 (DE-588)4292866-7 |
| title | Molecular aspects of anti-cancer drug action |
| title_auth | Molecular aspects of anti-cancer drug action |
| title_exact_search | Molecular aspects of anti-cancer drug action |
| title_full | Molecular aspects of anti-cancer drug action ed. by Stephen Neidle ... |
| title_fullStr | Molecular aspects of anti-cancer drug action ed. by Stephen Neidle ... |
| title_full_unstemmed | Molecular aspects of anti-cancer drug action ed. by Stephen Neidle ... |
| title_short | Molecular aspects of anti-cancer drug action |
| title_sort | molecular aspects of anti cancer drug action |
| topic | Acridines gtt Anthracyclinen gtt Anticarcinogene stoffen gtt Bleomycine gtt Nucleïnezuren gtt Structuur-activiteit-relatie gtt Antineoplastic Agents pharmacology Antineoplastic agents DNA Molecular biology Pharmacology, Experimental Cytostatikum (DE-588)4068347-3 gnd QSAR (DE-588)4205429-1 gnd Wirkungsmechanismus (DE-588)4292866-7 gnd |
| topic_facet | Acridines Anthracyclinen Anticarcinogene stoffen Bleomycine Nucleïnezuren Structuur-activiteit-relatie Antineoplastic Agents pharmacology Antineoplastic agents DNA Molecular biology Pharmacology, Experimental Cytostatikum QSAR Wirkungsmechanismus |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=000246134&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV000015093 |
| work_keys_str_mv | AT neidlestephen molecularaspectsofanticancerdrugaction |